BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8642629)

  • 21. Insertional mutagenesis and deep profiling reveals gene hierarchies and a Myc/p53-dependent bottleneck in lymphomagenesis.
    Huser CA; Gilroy KL; de Ridder J; Kilbey A; Borland G; Mackay N; Jenkins A; Bell M; Herzyk P; van der Weyden L; Adams DJ; Rust AG; Cameron E; Neil JC
    PLoS Genet; 2014 Feb; 10(2):e1004167. PubMed ID: 24586197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
    Amtoft HW; Sørensen AB; Bareil C; Schmidt J; Luz A; Pedersen FS
    J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.
    Blyth K; Terry A; O'Hara M; Baxter EW; Campbell M; Stewart M; Donehower LA; Onions DE; Neil JC; Cameron ER
    Oncogene; 1995 May; 10(9):1717-23. PubMed ID: 7753548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
    Johnson C; Lobelle-Rich PA; Puetter A; Levy LS
    J Virol; 2005 Jan; 79(1):57-66. PubMed ID: 15596801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleotide sequence of the first exon of the rat c-myc gene: proviral insertions in murine leukemia virus-induced lymphomas do not affect exon 1.
    Steffen DL; Nacar EQ
    Virology; 1988 May; 164(1):55-63. PubMed ID: 3284178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation.
    Belli B; Patel A; Fan H
    J Virol; 1995 Feb; 69(2):1037-43. PubMed ID: 7815481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duplication of U3 sequences in the long terminal repeat of mink cell focus-inducing viruses generates redundancies of transcription factor binding sites important for the induction of thymomas.
    DiFronzo NL; Frieder M; Loiler SA; Pham QN; Holland CA
    J Virol; 2003 Mar; 77(5):3326-33. PubMed ID: 12584358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region.
    Stewart M; Cameron E; Campbell M; McFarlane R; Toth S; Lang K; Onions D; Neil JC
    Int J Cancer; 1993 Apr; 53(6):1023-30. PubMed ID: 8473043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of recombinant nonecotropic murine leukemia viruses from the wild mouse species Mus spretus.
    Jung YT; Wu T; Kozak CA
    J Virol; 2003 Dec; 77(23):12773-81. PubMed ID: 14610199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncogenesis by Moloney murine leukemia virus.
    Tsichlis PN
    Anticancer Res; 1987; 7(2):171-80. PubMed ID: 3592629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical induction of thymomas in AKR mice: interaction of chemical carcinogens and endogenous murine leukemia viruses. Comparison of N-methyl-N-nitrosourea and methyl methanesulphonate.
    Warren W; Clark JP; Gardner E; Harris G; Cooper CS; Lawley PD
    Mol Carcinog; 1990; 3(3):126-33. PubMed ID: 2164817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation.
    Ceci JD; Patriotis CP; Tsatsanis C; Makris AM; Kovatch R; Swing DA; Jenkins NA; Tsichlis PN; Copeland NG
    Genes Dev; 1997 Mar; 11(6):688-700. PubMed ID: 9087424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line.
    Wang Y; Ramqvist T; Szekely L; Axelson H; Klein G; Wiman KG
    Cell Growth Differ; 1993 Jun; 4(6):467-73. PubMed ID: 8373731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging.
    van Lohuizen M; Verbeek S; Scheijen B; Wientjens E; van der Gulden H; Berns A
    Cell; 1991 May; 65(5):737-52. PubMed ID: 1904008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.
    Nielsen AA; Sørensen AB; Schmidt J; Pedersen FS
    J Virol; 2005 Jan; 79(1):67-78. PubMed ID: 15596802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer.
    Mikkers H; Allen J; Knipscheer P; Romeijn L; Hart A; Vink E; Berns A
    Nat Genet; 2002 Sep; 32(1):153-9. PubMed ID: 12185366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
    Kapoun AM; Shackleford GM
    Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice.
    Landesman-Bollag E; Channavajhala PL; Cardiff RD; Seldin DC
    Oncogene; 1998 Jun; 16(23):2965-74. PubMed ID: 9662328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.
    Zörnig M; Schmidt T; Karsunky H; Grzeschiczek A; Möröy T
    Oncogene; 1996 Apr; 12(8):1789-801. PubMed ID: 8622900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analysis of tumours from feline immunodeficiency virus (FIV)-infected cats: an indirect role for FIV?
    Terry A; Callanan JJ; Fulton R; Jarrett O; Neil JC
    Int J Cancer; 1995 Apr; 61(2):227-32. PubMed ID: 7705953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.